- Investing Ideas
- Belgian Pharmaceuticals & Biotech Most Popular Stocks
Belgian Pharmaceuticals & Biotech Most Popular Stocks
Results
8
Most Popular Stocks on the market
8 companies
UCB
Market Cap: €45.4b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€238.60
7D
-0.2%
1Y
45.8%
argenx
Market Cap: €42.9b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€690.40
7D
0.5%
1Y
32.3%
Financière de Tubize
Market Cap: €9.2b
Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium.
TUB
€206.20
7D
2.2%
1Y
61.6%
Hyloris Pharmaceuticals
Market Cap: €143.9m
Engages in the research, development, and manufacture of pharmaceutical products to address medical needs.
HYL
€5.14
7D
-3.7%
1Y
-9.5%
European Medical Solutions
Market Cap: €21.2m
Engages in the design, development, and manufacturing of medical imaging systems for digital radiology and bone densitometry in Belgium and internationally.
ALEMS
€5.00
7D
2.5%
1Y
0%
Celyad Oncology
Market Cap: €13.4m
A biotechnology company, focuses on unlocking the potential of its intellectual property.
CYAD
€0.30
7D
2.7%
1Y
-36.4%
BioSenic
Market Cap: €1.3m
A biotechnology company, develops cell therapy products and treatments for autoimmune and inflammatory diseases in Belgium and France.
BIOS
€0.002
7D
-9.1%
1Y
17.6%
Oxurion
Market Cap: €319.3k
A biopharmaceutical company, develops medicines to prevent blindness in Belgium.
OXUR
€0.0036
7D
-14.3%
1Y
-94.0%